Post-Acute Sequelae of COVID-19 (PASC)
Showing 1 - 25 of >10,000
COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of
Enrolling by invitation
- COVID-19
- +2 more
- Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
-
Kunming, Yunnan, ChinaSheng'Ai Traditional Medicine Hospital
Sep 22, 2023
Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection Trial (Comprehensive Rehabilitation, Augmented
Not yet recruiting
- Post-Acute COVID-19
- +7 more
- Comprehensive Rehabilitation
- Augmented Usual Care
- (no location specified)
Nov 28, 2023
Long COVID Trial in Boston (whole body hyperthermia)
Not yet recruiting
- Long COVID
- whole body hyperthermia
-
Boston, MassachusettsDepression Clinical and Research Program
Jul 5, 2023
Effect of Apollo Wearable on Long COVID-19 Symptoms.
Recruiting
- Post-acute Sequelae of SARS-COV-2 Infection
-
Pittsburgh, PennsylvaniaThe Board of Medicine
Oct 25, 2023
Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)
Not yet recruiting
- Long COVID-19
- Long COVID
- Paxlovid 25 day dosing
- +2 more
- (no location specified)
Jul 25, 2023
Long COVID, Long Covid19, Long Covid-19 Trial in Houston, San Antonio (BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE)
Not yet recruiting
- Long COVID
- +2 more
- BrainHQ/Active Comparator Activity
- +4 more
-
Houston, Texas
- +1 more
Aug 1, 2023
Post Acute Sequelae Covid-19 Hyposmia Trial in Durham (drug, other, device)
Not yet recruiting
- Post Acute Sequelae Covid-19 Hyposmia
- Beclomethasone
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jul 24, 2023
Long COVID, Long Covid19, Long Covid-19 Trial in Houston, San Antonio (BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE)
Not yet recruiting
- Long COVID
- +2 more
- BrainHQ/Active Comparator Activity
- +4 more
-
Houston, Texas
- +1 more
Aug 1, 2023
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Using TSPO
Recruiting
- Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
- PET Tracer
- +2 more
-
New York, New YorkNYU Langone Health
Nov 7, 2022
Dysexecutive Syndrome, Post-Acute Sequelae of COVID-19 Trial in Charlestown (Active tDCS, Sham tDCS)
Not yet recruiting
- Dysexecutive Syndrome
- Post-Acute Sequelae of COVID-19
- Active tDCS
- Sham tDCS
-
Charlestown, MassachusettsMassachusetts General Hospital
Apr 4, 2022
Post-acute Sequelae of SARS-CoV-2 Infection, Long COVID Trial in Stanford (Nirmatrelvir, Placebo, Ritonavir)
Recruiting
- Post-acute Sequelae of SARS-CoV-2 Infection
- Long COVID
- Nirmatrelvir
- +2 more
-
Stanford, CaliforniaStanford University
Dec 12, 2022
Cognitive Impairment, Post-Acute Sequelae of SARS-CoV-2 Infection, COVID-19 Trial (Active tDCS and cognitive training, Sham tDCS
Not yet recruiting
- Cognitive Impairment
- +2 more
- Active tDCS and cognitive training
- Sham tDCS and cognitive training
- (no location specified)
May 31, 2022
Post-acute Sequelae SARS-CoV-2 Infection (PASC) Trial in Minneapolis (Active tDCS, Sham tDCS)
Not yet recruiting
- Post-acute Sequelae SARS-CoV-2 Infection (PASC)
- Active tDCS
- Sham tDCS
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 2, 2023
Long COVID, Dysautonomia Trial in Los Angeles (Mindfulness - Mindful Awareness Practices ( MAPs))
Recruiting
- Long COVID
- Dysautonomia
- Mindfulness - Mindful Awareness Practices ( MAPs)
-
Los Angeles, CaliforniaUCLA Health
Jan 20, 2023
Post-Acute COVID-19, Post Acute COVID-19 Syndrome, Cognitive Dysfunction Trial in Madrid (CCT Long COVID)
Not yet recruiting
- Post-Acute COVID-19
- +3 more
- CCT Long COVID
-
Madrid, SpainUniversidad Nebrija
Oct 16, 2022
Post Acute COVID-19 Syndrome, Long COVID, Long Covid19 Trial in New York (stellate ganglion block with 0.5% bupivacaine)
Recruiting
- Post Acute COVID-19 Syndrome
- +14 more
- stellate ganglion block with 0.5% bupivacaine
-
New York, New YorkHudson Medical
Jan 10, 2023
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection Trial in Oxford (AXA1125, Placebo)
Active, not recruiting
- Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
- AXA1125
- Placebo
-
Oxford, United KingdomOxford University Hospitals NHS Foundation Trust
Jun 5, 2022
COVID-19 Trial in Frisco (Exercise Prescription)
Not yet recruiting
- COVID-19
- Exercise Prescription
-
Frisco, TexasBaylor Scott and White Sports Therapy and Research
Jan 31, 2022
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID Trial in United States (TNX-102 SL, Placebo SL Tablet)
Recruiting
- Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
- +3 more
- TNX-102 SL
- Placebo SL Tablet
-
Atlanta, Georgia
- +4 more
Jul 26, 2022
COVID-19 Trial in Atlanta (Low-dose Naltrexone (LDN), Cetirizine, Famotidine)
Not yet recruiting
- COVID-19
- Low-dose Naltrexone (LDN)
- +5 more
-
Atlanta, Georgia
- +3 more
Jul 12, 2023
COVID-19, SAR Trial in Hanover (CBDRA60 supplement, Placebo)
Not yet recruiting
- COVID-19
- SAR
- CBDRA60 supplement
- Placebo
-
Hanover, MichiganAnewsha Therapeutics / Comco R&D
Feb 18, 2022
Skeletal Muscle in PASC Patients
Recruiting
- LONG-COVID
- Post-acute Sequelae of COVID-19
- Bike exertion test
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam university medical centre AMC
Feb 3, 2022
Depression, Anxiety, Inflammation, COVID-19 Trial in Baltimore (Placebo, 300mg MYMD-1, 600mg MYMD-1)
Not yet recruiting
- Depression, Anxiety
- +2 more
- Placebo
- +2 more
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Feb 7, 2022